Neuland Laboratories Ltd
NSE:NEULANDLAB

Watchlist Manager
Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd
NSE:NEULANDLAB
Watchlist
Price: 14 904.95 INR 0.93% Market Closed
Market Cap: 191.2B INR
Have any thoughts about
Neuland Laboratories Ltd?
Write Note

Intrinsic Value

The intrinsic value of one NEULANDLAB stock under the Base Case scenario is 5 499.33 INR. Compared to the current market price of 14 904.95 INR, Neuland Laboratories Ltd is Overvalued by 63%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NEULANDLAB Intrinsic Value
5 499.33 INR
Overvaluation 63%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Neuland Laboratories Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NEULANDLAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NEULANDLAB?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Neuland Laboratories Ltd

Provide an overview of the primary business activities
of Neuland Laboratories Ltd.

What unique competitive advantages
does Neuland Laboratories Ltd hold over its rivals?

What risks and challenges
does Neuland Laboratories Ltd face in the near future?

Has there been any significant insider trading activity
in Neuland Laboratories Ltd recently?

Summarize the latest earnings call
of Neuland Laboratories Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neuland Laboratories Ltd.

Provide P/S
for Neuland Laboratories Ltd.

Provide P/E
for Neuland Laboratories Ltd.

Provide P/OCF
for Neuland Laboratories Ltd.

Provide P/FCFE
for Neuland Laboratories Ltd.

Provide P/B
for Neuland Laboratories Ltd.

Provide EV/S
for Neuland Laboratories Ltd.

Provide EV/GP
for Neuland Laboratories Ltd.

Provide EV/EBITDA
for Neuland Laboratories Ltd.

Provide EV/EBIT
for Neuland Laboratories Ltd.

Provide EV/OCF
for Neuland Laboratories Ltd.

Provide EV/FCFF
for Neuland Laboratories Ltd.

Provide EV/IC
for Neuland Laboratories Ltd.

Show me price targets
for Neuland Laboratories Ltd made by professional analysts.

What are the Revenue projections
for Neuland Laboratories Ltd?

How accurate were the past Revenue estimates
for Neuland Laboratories Ltd?

What are the Net Income projections
for Neuland Laboratories Ltd?

How accurate were the past Net Income estimates
for Neuland Laboratories Ltd?

What are the EPS projections
for Neuland Laboratories Ltd?

How accurate were the past EPS estimates
for Neuland Laboratories Ltd?

What are the EBIT projections
for Neuland Laboratories Ltd?

How accurate were the past EBIT estimates
for Neuland Laboratories Ltd?

Compare the revenue forecasts
for Neuland Laboratories Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Neuland Laboratories Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neuland Laboratories Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neuland Laboratories Ltd compared to its peers.

Compare the P/E ratios
of Neuland Laboratories Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Neuland Laboratories Ltd with its peers.

Analyze the financial leverage
of Neuland Laboratories Ltd compared to its main competitors.

Show all profitability ratios
for Neuland Laboratories Ltd.

Provide ROE
for Neuland Laboratories Ltd.

Provide ROA
for Neuland Laboratories Ltd.

Provide ROIC
for Neuland Laboratories Ltd.

Provide ROCE
for Neuland Laboratories Ltd.

Provide Gross Margin
for Neuland Laboratories Ltd.

Provide Operating Margin
for Neuland Laboratories Ltd.

Provide Net Margin
for Neuland Laboratories Ltd.

Provide FCF Margin
for Neuland Laboratories Ltd.

Show all solvency ratios
for Neuland Laboratories Ltd.

Provide D/E Ratio
for Neuland Laboratories Ltd.

Provide D/A Ratio
for Neuland Laboratories Ltd.

Provide Interest Coverage Ratio
for Neuland Laboratories Ltd.

Provide Altman Z-Score Ratio
for Neuland Laboratories Ltd.

Provide Quick Ratio
for Neuland Laboratories Ltd.

Provide Current Ratio
for Neuland Laboratories Ltd.

Provide Cash Ratio
for Neuland Laboratories Ltd.

What is the historical Revenue growth
over the last 5 years for Neuland Laboratories Ltd?

What is the historical Net Income growth
over the last 5 years for Neuland Laboratories Ltd?

What is the current Free Cash Flow
of Neuland Laboratories Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Neuland Laboratories Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neuland Laboratories Ltd

Current Assets 9.2B
Cash & Short-Term Investments 1.2B
Receivables 3.7B
Other Current Assets 4.3B
Non-Current Assets 9.1B
Long-Term Investments 287.7m
PP&E 5.7B
Intangibles 2.8B
Other Non-Current Assets 321.8m
Current Liabilities 4.3B
Accounts Payable 1.9B
Other Current Liabilities 2.4B
Non-Current Liabilities 1.2B
Long-Term Debt 541.2m
Other Non-Current Liabilities 680.5m
Efficiency

Earnings Waterfall
Neuland Laboratories Ltd

Revenue
16.4B INR
Cost of Revenue
-7.6B INR
Gross Profit
8.7B INR
Operating Expenses
-4.5B INR
Operating Income
4.3B INR
Other Expenses
-905.6m INR
Net Income
3.4B INR

Free Cash Flow Analysis
Neuland Laboratories Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NEULANDLAB Profitability Score
Profitability Due Diligence

Neuland Laboratories Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Exceptional 3-Years Revenue Growth
ROIC is Increasing
66/100
Profitability
Score

Neuland Laboratories Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

NEULANDLAB Solvency Score
Solvency Due Diligence

Neuland Laboratories Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
90/100
Solvency
Score

Neuland Laboratories Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NEULANDLAB Price Targets Summary
Neuland Laboratories Ltd

Wall Street analysts forecast NEULANDLAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEULANDLAB is 17 977.5 INR with a low forecast of 15 402.5 INR and a high forecast of 21 000 INR.

Lowest
Price Target
15 402.5 INR
3% Upside
Average
Price Target
17 977.5 INR
21% Upside
Highest
Price Target
21 000 INR
41% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NEULANDLAB?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NEULANDLAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NEULANDLAB Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

191.2B INR

Dividend Yield

0.09%

Description

Neuland Laboratories Ltd. manufactures and exports bulk pharmaceutical ingredients and intermediates for the generics industry. The company is headquartered in Hyderabad, Telangana and currently employs 1,521 full-time employees. The firm is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The firm operates through manufacture of active pharmaceutical ingredients and allied services. The firm has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services. The Company’s capabilities include FBRM, research and development, peptide laboratory, poly block reactors, laboratory reactors, heating and cooling systems, hazardous and wet laboratory, PID Laboratory Unit-III, PID Laboratory B-S Unit-I, and other lab equipment. The firm has 3 manufacturing facilities and one R&D facility in Hyderabad.

Contact

TELANGANA
Hyderabad
Sanali Info Park, A Block, Ground Floor, 8-2-120/113, Road No. 2, Banjara Hills
+914030211600
www.neulandlabs.com

IPO

1994-04-18

Employees

1 521

Officers

Executive Chairman & Chief Promoter and Member of Scientific Advisory Board
Dr. Davuluri Rama Mohan Rao
Vice Chairman & CEO
Mr. Davuluri Sucheth Rao
Vice Chairman & MD
Mr. Davuluri Saharsh Rao
Chief Financial Officer
Mr. Abhijit Majumdar
Chief Scientific Officer & Member of Scientific Advisory Board
Dr. Sharadsrikar Venkatesan Kotturi
Company Secretary & Compliance Officer
Ms. Sarada Bhamidipati
Show More
Senior VP of Global Head Sales & BD
Mr. Sudheer Yarabolu
Chief Human Resources Officer
Mr. Hemchandra Peruvelli
Senior Vice President of Global API Sales
Mr. Y. Sudheer
Chief Procurement Officer
Mr. N. Sundar
Show Less

See Also

Discover More
What is the Intrinsic Value of one NEULANDLAB stock?

The intrinsic value of one NEULANDLAB stock under the Base Case scenario is 5 499.33 INR.

Is NEULANDLAB stock undervalued or overvalued?

Compared to the current market price of 14 904.95 INR, Neuland Laboratories Ltd is Overvalued by 63%.

Back to Top